Several candidate biomarkers are being studied for HCC diagnosis, with des-gamma-carboxy prothrombin (DCP), lens cullinaris agglutin-reactive AFP (AFP-L3), osteopontin, and midkine, amongst others, the most advanced in development. The gene discussed is AFP; the disease is hepatocellular carcinoma.